15 Deaths During Use Of Hep C Drug Telavic Since Japan Launch
This article was originally published in PharmAsia News
Executive Summary
Of the Japanese patients who have been prescribed the hepatitis C drug Telavic (telaprevir) since its launch in 2011, 23% have experienced severe side-effects such as dermatitis and systemic liver failure and 15 people have died.